FYI:
Stanford University started recruiting patients with non-Hodgkin Lymphomas for phase 1 clinical trial of their recently announced experimental cancer vaccine.
The clinical trial ID is NCT03410901. The trial description states:
Anticipated Study Start Date : March 1, 2018
Estimated Primary Completion Date : September 1, 2020
Estimated Study Completion Date : September 1, 2020
Furthermore, trial reports will be generated for 24, 48, 72 and 96 weeks.
If I understand correctly, we with other types of cancer may have to wait for quite a while to have a chance joining future rounds of its clinical trials even the cancer vaccine is proven to be effective for Lymphoma.